Barron's Streetwise cover image

The First $100 Billion Drug

Barron's Streetwise

00:00

The Progress in Oncology and Immunotherapy

Despite the likely approval of SI and biogen's drug, it's called lakana map. There's still a lot in the oncology and hematology space. Obesity, I think, is going to be really the for a few years commercially. The Wall Street Journal's Your Money Briefing podcast breaks down complex financial issues.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app